Swiss National Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.27M | Hold |
220,600
| – | – | ﹤0.01% | 1590 |
|
|
2025
Q4 | $3.52M | Sell |
220,600
-2,300
| -1% | -$32.6K | ﹤0.01% | 1564 |
|
|
2025
Q3 | $2.46M | Hold |
222,900
| – | – | ﹤0.01% | 1751 |
|
|
2025
Q2 | $1.89M | Sell |
222,900
-12,900
| -5% | -$103K | ﹤0.01% | 1833 |
|
|
2025
Q1 | $1.9M | Sell |
235,800
-3,200
| -1% | -$25.9K | ﹤0.01% | 1795 |
|
|
2024
Q4 | $2.15M | Sell |
239,000
-26,200
| -10% | -$214K | ﹤0.01% | 1814 |
|
|
2024
Q3 | $1.94M | Sell |
265,200
-3,300
| -1% | -$20.5K | ﹤0.01% | 1881 |
|
|
2024
Q2 | $1.53M | Hold |
268,500
| – | – | ﹤0.01% | 1947 |
|
|
2024
Q1 | $1.35M | Hold |
268,500
| – | – | ﹤0.01% | 2068 |
|
|
2023
Q4 | $2.41M | Sell |
268,500
-30,200
| -10% | -$249K | ﹤0.01% | 1725 |
|
|
2023
Q3 | $2.32M | Buy |
298,700
+19,400
| +7% | +$190K | ﹤0.01% | 1742 |
|
|
2023
Q2 | $2.7M | Buy |
279,300
+18,600
| +7% | +$193K | ﹤0.01% | 1692 |
|
|
2023
Q1 | $2.86M | Sell |
260,700
-30,500
| -10% | -$269K | ﹤0.01% | 1615 |
|
|
2022
Q4 | $1.26M | Buy |
291,200
+5,500
| +2% | +$31.9K | ﹤0.01% | 2214 |
|
|
2022
Q3 | $2.15M | Buy |
285,700
+25,100
| +10% | +$217K | ﹤0.01% | 1824 |
|
|
2022
Q2 | $2.62M | Hold |
260,600
| – | – | ﹤0.01% | 1729 |
|
|
2022
Q1 | $3.23M | Buy |
260,600
+20,400
| +8% | +$315K | ﹤0.01% | 1739 |
|
|
2021
Q4 | $5.49M | Buy |
240,200
+13,700
| +6% | +$325K | ﹤0.01% | 1408 |
|
|
2021
Q3 | $5.01M | Buy |
226,500
+1,000
| +0.4% | +$15.9K | ﹤0.01% | 1461 |
|
|
2021
Q2 | $2.93M | Sell |
225,500
-20,400
| -8% | -$260K | ﹤0.01% | 1848 |
|
|
2021
Q1 | $3.2M | Buy |
245,900
+1,900
| +0.8% | +$27.6K | ﹤0.01% | 1721 |
|
|
2020
Q4 | $3.37M | Hold |
244,000
| – | – | ﹤0.01% | 1609 |
|
|
2020
Q3 | $3.58M | Buy |
244,000
+63,400
| +35% | +$918K | ﹤0.01% | 1390 |
|
|
2020
Q2 | $2.91M | Buy |
180,600
+23,200
| +15% | +$371K | ﹤0.01% | 1492 |
|
|
2020
Q1 | $2.24M | Buy |
157,400
+4,900
| +3% | +$86.4K | ﹤0.01% | 1378 |
|
|
2019
Q4 | $3.08M | Buy |
152,500
+30,500
| +25% | +$281K | ﹤0.01% | 1472 |
|
|
2019
Q3 | $651K | Buy |
122,000
+10,200
| +9% | +$61.7K | ﹤0.01% | 2266 |
|
|
2019
Q2 | $738K | Buy |
111,800
+13,700
| +14% | +$87.3K | ﹤0.01% | 2283 |
|
|
2019
Q1 | $637K | Hold |
98,100
| – | – | ﹤0.01% | 2291 |
|
|
2018
Q4 | $667K | Buy |
98,100
+5,700
| +6% | +$32.9K | ﹤0.01% | 2229 |
|
|
2018
Q3 | $608K | Hold |
92,400
| – | – | ﹤0.01% | 2362 |
|
|
2018
Q2 | $530K | Hold |
92,400
| – | – | ﹤0.01% | 2428 |
|
|
2018
Q1 | $486K | Hold |
92,400
| – | – | ﹤0.01% | 2381 |
|
|
2017
Q4 | $421K | Buy |
+92,400
| New | +$513K | ﹤0.01% | 2443 |
|
Other funds holding AUPH
TCM
NMC
Swiss National Bank's AUPH Position: Q1 2026 in Review
Swiss National Bank held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 220,600 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1590.
Swiss National Bank first reported a position in AUPH in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.49M in Q4 2021. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.
- Swiss National Bank held 220,600 shares of Aurinia Pharmaceuticals worth $3.27M as of Q1 2026.
- Swiss National Bank left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1590 holding.
- Swiss National Bank first reported a position in Aurinia Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- Swiss National Bank's Aurinia Pharmaceuticals position peaked at $5.49M in Q4 2021.
- 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.